Conference call to be held on Tuesday, February 13, 2024, at 8:30 a.m. Eastern Time
YOKNEAM, Israel,
Jan. 16,
2024 /PRNewswire/ -- InMode Ltd.
(Nasdaq: INMD), a leading
global provider of innovative medical technologies, announced today
that it expects to release its financial results for the fourth
quarter and full year 2023 before the Nasdaq market opens
on Tuesday, February 13, 2024.
InMode is currently finalizing its financial results for
the fourth quarter and full year of 2023. While complete financial
information and operating data are not yet available, set forth
below are certain preliminary financial results for said period,
subject to final adjustments and other developments that may arise
between now and the time such financial results are published.
Based on preliminary results, management expects:
- Revenue for the fourth quarter of 2023 to be in the range
of $126.0 million to $126.5 million and revenue for
the full year of 2023 to be in the range of $491.3 million to $491.8
million
- Non-GAAP1 earnings per diluted share for
the fourth quarter and full year of 2023 to be in the range
of $0.68 to $0.69 and $2.54 to $2.55,
respectively
- Non-GAAP1 gross margin for the full year of
2023 to be in the range of 83% to 85%
- Full year 2024 revenue to be in the range of $495 million to $505
million
1Please refer to "Use of
Non-GAAP Financial Measures" below for important information about
non-GAAP financial measures. Non-GAAP results exclude share-based
compensation.
InMode will host a conference call to
discuss the fourth quarter and full year 2023 financial results on
February 13, at 8:30 a.m. Eastern Time with presentations from
management including Moshe Mizrahy,
Chairman and Chief Executive Officer; Yair
Malca, Chief Financial Officer; Dr. Michael Kreindel, Chief Technology Officer;
Shakil Lakhani, President of
North America; and Dr.
Spero Theodorou, Chief Medical
Officer.
The Company encourages participants
to pre-register for the conference call using the following
link:
https://dpregister.com/sreg/10185217/fb446e05e4.Callers
will receive a unique dial-in upon registration, which enables
immediate access on the day of the call. Participants may
pre-register at any time, including up to and after the call start
time.
For callers that opt out of pre-registration, please dial
one of the following teleconferencing numbers. Please begin by
placing your call 10 minutes before the conference call commences.
If you are unable to connect using the toll-free number, please try
the international dial-in number.
U.S. Toll-Free: 1-833-316-0562
Israel Toll-Free:
1-80-921-2373
International:
1-412-317-5736
Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6h4ExUgZ
At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
The conference call will also be webcast live from a link
on InMode's website
at https://inmodemd.com/investors/events-presentations/.
A replay of the conference call will be available
from February 13, 2024, at 12:00 p.m. Eastern
Time to February 27, 2024, at 11:59 p.m.
Eastern Time. To access the replay, please dial one of the
following numbers:
Replay U.S. TOLL-FREE:
1-877-344-7529
Replay TOLL/INTERNATIONAL: 1-412-317-0088
Replay Pin Number: 6723856
A replay will also be available for 90 days on InMode's
website
at: https://inmodemd.com/investors/events-presentations/.
About InMode
InMode is a leading global provider of
innovative medical technologies. InMode develops, manufactures, and
markets devices harnessing novel radiofrequency ("RF") technology.
InMode strives to enable new emerging surgical procedures as well
as improve existing treatments. InMode has leveraged its medically
accepted minimally-invasive RF technologies to offer a
comprehensive line of products across several categories for
plastic surgery, gynecology, dermatology, otolaryngology, and
ophthalmology. For more information about InMode and its wide array
of medical technologies, visit
www.inmodemd.com.
Forward-Looking
Statements
The information in this press release includes
forward-looking statements within the meaning of the federal
securities laws. These statements generally relate to future events
or InMode's future financial or operating performance,
including the 2024 revenue projection described above.
Actual outcomes and results may differ materially from what
is expressed or forecast in such forward-looking statements. In
some cases, you can identify these statements because they contain
words such as "anticipate," "believe," "estimate," "expect,"
"intend," "may," "plan," "predict," "project," "will," "would" and
similar expressions that concern our expectations, strategic plans
or intentions. Forward-looking statements are based on management's
current expectations and assumptions, and are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. Consequently, actual results could differ
materially from those indicated in these forward-looking
statements. When considering these forward-looking statements, you
should keep in mind the risk factors and other cautionary
statements included in InMode's Annual Report on Form 20-F filed
with the Securities and Exchange Commission on February 14, 2023, and our future public filings.
InMode undertakes no obligation and does not intend to update these
forward-looking statements to reflect events or circumstances
occurring after this press release. You are cautioned not to place
undue reliance on these forward-looking statements, which pertain
only as of the date of this press release.
Use of Non-GAAP Financial
Measures
In addition to InMode's operating results
presented in accordance with GAAP, this release includes certain
non-GAAP financial measures including non-GAAP net income, non-GAAP
earnings per diluted share and non-GAAP operating margin. Because
these measures are used in InMode's internal analysis of financial
and operating performance, management believes that they provide
greater transparency to investors of management's view of InMode's
economic performance. Management also believes the presentation of
these measures, when analyzed in conjunction with InMode's GAAP
operating results, allows investors to evaluate and compare the
performance of InMode to that of its peers, although InMode's
presentation of its non-GAAP measures may not be comparable to
other similarly titled measures of other companies more
effectively.
Company
Contact:
Yair Malca
Chief Financial
Officer
Phone: (949)
305-0108
Email:
Yair.Malca@inmodemd.com
|
Investor Relations
Contact:
Miri Segal
MS-IR LLC
Phone: (917)
607-8654
Email:
ir@inmodemd.com
|
Logo -
https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/inmode-to-report-fourth-quarter--full-year-2023-financial-results-and-hold-conference-call-on-feb-13--2024--expects-q4-revenue-between-126-0m-126-5m-302034940.html
SOURCE InMode LTD